Document is current
Any future updates will be listed below
-
Authors
Okada, Kazuyoshi
Tashiro, Manabu
Michiwaki, Hiroyuki
Yamaguchi, Sumiyo
Inoue, Tomoko
Minakuchi, Jun
-
Clinical Trials BETA
Clinical trials referenced in this document:
umin000055718 at UMIN JapanDocuments that mention this clinical trial
High albumin leakage rather than increased dialysis dose can increase the α1-microglobulin reduction ratio in patients on predilution online hemodiafiltration
https://doi.org/10.1186/s41100-025-00604-z
- License Information
-
More Information
Article History
Received: 16 November 2024
Accepted: 30 January 2025
First Online: 14 February 2025
Declarations
:
: This study was approved by the Research Ethics Committee of Kawashima Hospital (1264–1266) and registered in the UMIN Clinical Trials Registry (UMIN000055718 registered on 3 October 2024, ). All clinical investigations were conducted according to the principles expressed in the Declaration of Helsinki. In accordance with the Ethical Guidelines for Life Science and Medical Research Involving Human Subjects, information about this research was disclosed to patients in this retrospective study before enrollment.
: Not applicable.
: All of the authors report funding for specific clinical research (Japan Registry of Clinical Trials registration number jRCTs062190020) from Asahi Kasei Medical Co., Ltd., and contract research and funding for specific clinical research (Japan Registry of Clinical Trials registration number jRCTs032220723) from Nipro Co., Ltd.
